Clinical laboratories
Reagents, consumables and automated analysers supplied to hospital and reference laboratories for routine and specialised in-vitro testing.
Intelligence / Healthtech & medtech market map / Diagnostics and laboratory products
Products and consumables used to analyse clinical specimens or physiological signals to detect, characterise or monitor disease. Includes in-vitro diagnostic reagents, analyser systems associated with those reagents, point-of-care testing kits, and diagnostic consumables; excludes general laboratory instruments and tools sold to life-science research organisations.
Split by customer type.
Reagents, consumables and automated analysers supplied to hospital and reference laboratories for routine and specialised in-vitro testing.
Rapid diagnostic tests and compact analysers used in physician practices, urgent-care centres, emergency departments and alternative-care sites.
Molecular assays, sequencing-based products and specialty diagnostic systems for targeted disease, oncology and inherited-condition testing, including associated reagents and consu
Single-use diagnostic consumables such as blood-collection, specimen-handling and swab products that support testing workflows but are not themselves assays.
$92.4B ($86.5B–$119B) · 2025 · Triangulated
Published estimates for clinical diagnostics span USD 86.5bn (2025, FMI [9]) to USD 118.6bn (2025, Phoenix [3][4]); Credence Research gives USD 92.37bn for 2025 rising to USD 147.31bn by 2035 at 4.78% CAGR [1]. Central point taken at USD 92.37bn (2025) with a range of 86.5-118.6bn reflecting definitional spread (kits vs kits+instruments+services). North America held 40.0% of global value in 2025 [1].
// Sell into Diagnostics and laboratory products